BEGIN:VCALENDAR
PRODID:-//github.com/ical-org/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:All are welcome. Lecture Title: "Management of Advanced Cutane
 ous Squamous Cell Carcinoma: The Patient Journey from Diagnosis to Surviv
 orship" Emily Ruiz\, MD\, MPH\, is an associate physician at the Mohs and
  Dermatologic Surgery Center at Brigham and Women's Faulkner Hospital\; a
 ssociate professor in dermatology at Harvard Medical School\; and program
  director and director of the High-Risk Skin Cancer Clinic at Dana-Farber
  Brigham Cancer Center. Ruiz received her undergraduate degree from Duke 
 University\, her medical degree from New York University Grossman School 
 of Medicine\, and her master of public health degree from Harvard T.H. Ch
 an School of Public Health. She completed an internship in internal medic
 ine at New York University Grossman School of Medicine\, a dermatology re
 sidency at Albert Einstein College of Medicine\, and a fellowship in micr
 ographic surgery and dermatologic oncology at Brigham and Women's Hospita
 l. Ruiz's career is dedicated to patient care\, clinical innovation\, edu
 cation\, and skin cancer research. She spends 40% of her time in outpatie
 nt clinical activities\, and the remainder is devoted to clinical researc
 h and education. Most of her clinical time is spent performing Mohs micro
 graphic surgery\, and one clinic a week is at Dana-Farber Cancer Institut
 e. This clinic is a referral site for aggressive non-melanoma skin cancer
 s. It provides skin cancer surveillance to high-risk patients\, including
  transplant patients and individuals with a history of high-risk skin can
 cer. It is also a site for two clinical trials for a programmed cell deat
 h protein 1 (PD-1) inhibitor for patients with locally advanced and metas
 tatic cutaneous squamous cell carcinoma and basal cell carcinoma. Ruiz's 
 primary research interest is focused on prognostics and treatment of cuta
 neous squamous cell carcinoma (CSCC). She has received foundation grants 
 to develop surveillance protocols for CSCC\, assessed dermatologist-perfo
 rmed ultrasound\, and improved prognostication of CSCC. She has National 
 Institutes of Health (NIH) funding for a project that will incorporate ar
 tificial intelligence into CSCC prognostication. She lives in Boston with
  her husband and daughters.\n\nSpeaker:\nEmily Ruiz\, MD\, MPH\n\nAdmissi
 on:\nFree\n\nDetails URL:\nhttps://medicine.yale.edu/event/visiting-profe
 ssor-lecture-emily-ruiz-md-mph/\n
DTEND;TZID=America/New_York:20260527T110000
DTSTAMP:20260514T190341Z
DTSTART;TZID=America/New_York:20260527T100000
GEO:41.302774;-72.935109
LOCATION:Fitkin Memorial Pavilion Auditorium\, 789 Howard Avenue\, New Hav
 en\, CT\, United States
SEQUENCE:0
STATUS:Confirmed
SUMMARY:Visiting Professor Lecture
UID:18a15cc1-15bc-4e17-ba86-c56c64380463
END:VEVENT
END:VCALENDAR